Pay in 4 interest-free payments of $6.79 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
Agents targeting the glucagon-like peptide-1 receptor (GLP-1R) are effective in managing metabolic conditions associated with obesity, such as obstructive sleep apnea (OSA), metabolic dysfunction-associated steatotic liver disease (MASLD), and chronic kidney disease (CKD)
Medical weight loss is $60 initial and $60 per month
Mandavilli BS, Ali SF, Van Houten B (2000) DNA damage in brain mitochondria caused by aging and MPTP treatment
Some recent studies suggest GLP-1s are not cost-effective at their current prices, and increasing coverage could significantly raise overall spending, highlighting the challenge of balancing costs and benefits
Glucagon-like peptide 1 and atrial natriuretic peptide in a female mouse model of obstructive pulmonary disease
.webp)
US$ 23.09
US$ 22.16
US$ 23.82
US$ 29.85
US$ 25.01
US$ 27.58
US$ 24.68
US$ 27.00
